ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1191

Nicotinamide Adenine Dinucleotide Phosphate Oxidase Mediated Angiogenesis and Inflammation in the Arthritic Joint

Monika Biniecka1, Wei Gao2, Chin Teck Ng1, Emese Balogh2, Douglas J. Veale2 and Ursula Fearon2, 1Rheumatology, Translation Research Group, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 2Dublin Academic Medical Centre, St. Vincent's University Hospital, Translation Rheumatology Research Group, Dublin, Ireland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Angiogenesis, Arthroscopy, inflammatory arthritis and tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumamtoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: To examine the role of Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NADPH oxidase)-derived Reactive Oxygen Species (ROS) and NADPH oxidase-dependent redox signaling events in regulating angiogenesis and inflammation in the arthritic joint. Moreover to examine the effects of hypoxia, TNFi treatment and NADPH inhibitors on NADPH oxidase mediated angiogenesis and inflammation.

Methods: Patients with inflammatory arthritis (IA; n=48) underwent arthroscopy and synovial tissue oxygen (tpO2) measurements, synovial tissue biopsies and clinical assessment were obtained. Sixteen patients pre/post-TNFi therapy were also recruited. Macroscopic synovitis/vascularity was measured by visual analogue scale. Synovial levels of NADPH oxidase (isoform NOX2), cell-specific markers of inflammation (CD3, CD8, CD20, CD68), vascular factors (VEGF, Ang2, Factor VIII) and redox signaling factors (NF-κB, Akt, STAT3) were quantified by immunohistology/immunofluorescence. Using IA synovial explant cultures ex-vivo, the effect of the NOX2 inhibitors (DPI and APO) on IL-8 release was measured by ELISA. NOX2 protein levels were assessed in K4 cells (immortalised human synoviocytes) under normoxia and hypoxia (3%) by Western Blot. 

Results: Low in vivo pO2 levels in the inflamed joint (median [range] 26.6 [3.2–63] mm Hg) were related to increased microscopic expression of NOX2 (p=0.01; r=-0.43). In biologic responders in vivo tpO2 levels increased post treatment, which was associated with a significant reduction in NOX2 level (p<0.05). In contrast in non-responders where tpO2 levels remained the same or were reduced, no significant change in NOX2 expression was observed. Furthermore in vitro hypoxia (3%) induced NOX2 protein expression in K4 cells. High synovial NOX2 expression correlated with high macroscopic vascularity (p=0.005; r=0.46), synovitis (p=0.03; r=0.37), and with increased number of cell-specific markers of T cells (CD4 p=0.0001, r=0.90; CD8 p=0.002, r=0.72), B cells (CD20 p=0.003; r=0.82) and macrophages (CD68 p=0.01; r=0.44). There was a colocalisation and strong association between synovial NOX2 and expression of VEGF (p=0.005; r=0.52), Ang2 (p=0.05; r=0.32) and a number of blood vessels (p=0.004; r=0.50). In addition, synovial NOX2 expression was linked to redox activation of NF-κB, Akt, and STAT3 signaling pathways. Functionally, stimulation of synovial explants with DPI and APO alone or in combination with TNF significantly decreased secretion levels of IL-8.

Conclusion: NADPH oxidase is strongly expressed in synovial tissue and NADPH oxidase-derived ROS may mediate angiogenic and proinflammatory processes in the inflamed joint. Furthermore these effects may in part be mediated through hypoxic activation of downstream redox sensitive signaling events.


Disclosure:

M. Biniecka,
None;

W. Gao,
None;

C. T. Ng,
None;

E. Balogh,
None;

D. J. Veale,

Abbott Laboratories,

2,

MSD,

2,

Opsona,

2,

Pfizer Inc,

2,

Roche Pharmaceuticals,

2;

U. Fearon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nicotinamide-adenine-dinucleotide-phosphate-oxidase-mediated-angiogenesis-and-inflammation-in-the-arthritic-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology